Synthetic nanobodies targeting the SARS-CoV-2 receptor-binding domain
Walter JD, Hutter CAJ, Zimmermann I, Earp JD, Egloff P, Sorgenfrei M, Hürlimann LM, Gonda I, Meier G, Remm S, Thavarasah S, Plattet P, Seeger MA
BioRxiv 2020.04.16.045419
(Link opens in a new window)
Article
Plasmids from Article
ID | Plasmid | Purpose |
---|---|---|
153522 | pSb_init containing anti SARS-CoV-2_RBD sybody Sb#14 | Expression of the anti SARS-CoV-2_RBD sybody Sb#14 |
153523 | pSb_init containing anti SARS-CoV-2_RBD sybody Sb#15 | Expression of the anti SARS-CoV-2_RBD sybody Sb#15 |
153524 | pSb_init containing anti SARS-CoV-2_RBD sybody Sb#16 | Expression of the anti SARS-CoV-2_RBD sybody Sb#16 |
153525 | pSb_init containing anti SARS-CoV-2_RBD sybody Sb#42 | Expression of the anti SARS-CoV-2_RBD sybody Sb#42 |
153526 | pSb_init containing anti SARS-CoV-2_RBD sybody Sb#45 | Expression of the anti SARS-CoV-2_RBD sybody Sb#45 |
153527 | pSb_init containing anti SARS-CoV-2_RBD sybody Sb#68 | Expression of the anti SARS-CoV-2_RBD sybody Sb#68 |